Drawing for LIAISON

USPTO serial 87399567

LIAISON

Reviewed by CopyMark Law Group

Reg. 5868840Status 702Registered
Filing date
Status date
Registration date
Sep 24, 2019
Examiner
BEDNARZ, DUSTIN THOMAS
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with LIAISON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United States

Goods and services

ClassDescriptionStatusFirst use
001(Based on 1(a)) Diagnostic reagents for clinical or medical laboratory useACTIVEMar 10, 2004
005(Based on 1(a)) Diagnostic kits comprised of medical diagnostic reagents and assays for extraction, testing and analysis of bodily fluids, namely, extraction of viral nucleic acid, bacterial nucleic acid, stool DNA, blood DNA, and RNA, and for the extraction and isolation of blood cells; medical diagnostic reagents; diagnostic preparations for medical purposes; nucleic acid sequences for medical [ and veterinary ] purposes; [ diagnostic preparations for veterinary purposes; ] diagnostic preparations for medical [ and veterinary ] purposesACTIVEMar 10, 2004
009(Based on 44(e)) Scientific apparatus, namely, molecular biological and immunological testing systems, namely, microarray scanners, DNA and protein chips, kits for multiplex polymerase chain reaction (PCR) tests consisting primarily of optical and electronic apparatus for analyzing biological or biochemical samples, namely, electrophoresis apparatus, nucleic acid and protein sequencing apparatus, and polymerase chain reaction (PCR) thermal cyclers, including associated hardware and software therefor and also containing devices for removing, marking, applying and identifying biological or biochemical samples, pipettes, or cannulaeACTIVE—
010(Based on 44(e)) Medical diagnostic instruments for the analysis of body fluids, tissue, biomolecules, DNA, antibodies, proteins, molecular material, or cellular material; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of body fluid diagnostic testing, tissue-based diagnostic testing, molecular testing, protein testing, antibody testing, cytology and cell-based testing; electrical laboratory diagnostic instruments and apparatus for the analysis of nucleic acids and proteins for medical use; diagnostic kits consisting primarily of electronic instruments for medical diagnosis and analysis of body fluids, tissues, biomolecules, DNA, antibodies, proteins, molecular material or cellular materialACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 19, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 19, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 14, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Sep 24, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 24, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 22, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 21, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 5, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 15, 2019IUAFUSE AMENDMENT FILED—
May 15, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 14, 2019ISMRWITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST—
May 6, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 4, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 7, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 13, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 9, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 7, 2018EX1GSOU EXTENSION 1 GRANTED—
Nov 7, 2018EXT1SOU EXTENSION 1 FILED—
Nov 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 9, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 5, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Feb 5, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 5, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 5, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 11, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 11, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 11, 2018ALIEASSIGNED TO LIE—
Dec 25, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 5, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 5, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 5, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2017DOCKASSIGNED TO EXAMINER—
Apr 11, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 8, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance